tiprankstipranks
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
US Market

Pacira Pharmaceuticals Financial Overview

Pacira Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.051; its P/E ratio is ―; Pacira Pharmaceuticals is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $0.80. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 490.31M$ 467.53M$ 401.28M$ 312.32M$ 314.31M
Operating Income$ 87.67M$ 60.02M$ 89.92M$ 46.35M$ 10.48M
EBITDA$ 154.59M$ 140.38M$ 113.95M$ 63.51M$ 56.10M
Net Income$ 41.95M$ 15.91M$ 41.98M$ 145.52M$ -11.02M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 1.57B$ 1.68B$ 2.08B$ 1.27B$ 831.07M
Total Debt$ 586.04M$ 763.39M$ 1.13B$ 541.13M$ 351.92M
Net Debt$ 307.46M$ 474.74M$ 472.44M$ 19.47M$ 59.97M
Total Liabilities$ 704.26M$ 906.19M$ 1.34B$ 654.83M$ 476.12M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 139.49M$ 115.20M$ 79.85M$ 39.23M$ 60.36M
Operating Cash Flow$ 154.65M$ 145.27M$ 125.72M$ 77.03M$ 70.52M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Pacira Pharmaceuticals Earnings and Revenue History

Pacira Pharmaceuticals Debt to Assets

Pacira Pharmaceuticals Cash Flow

Pacira Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis